dc.contributor.author |
Ruiz, Joaquim |
|
dc.contributor.author |
Pons, M.J. |
|
dc.contributor.author |
Mosquito, S. |
|
dc.contributor.author |
Ochoa Woodell, Theresa Jean |
|
dc.contributor.author |
Vargas, M. |
|
dc.contributor.author |
Molina, M. |
|
dc.contributor.author |
Lluque, A. |
|
dc.contributor.author |
Gil, A.I. |
|
dc.contributor.author |
Ecker, L. |
|
dc.contributor.author |
Barletta, F. |
|
dc.contributor.author |
Lanata, C.F. |
|
dc.contributor.author |
del Valle, L.J. |
|
dc.date.accessioned |
2022-01-18T19:34:42Z |
|
dc.date.available |
2022-01-18T19:34:42Z |
|
dc.date.issued |
2012 |
|
dc.identifier.uri |
https://hdl.handle.net/20.500.12866/11165 |
|
dc.description.abstract |
The main aim of this study was to establish the resistance levels to antimicrobial agents, in 222 non-pathogenic E. Coli strains of fecal origin in Peru. The proportion of resistance found to the evaluated antimicrobials was ampicillin (62.6%), cotrimoxazole (48,6%), tetracycline (43,0%) and chloramphenicol (15,8%). We emphasize the high resistance levels found for quinolones: 32% for nalidixic acid (NAL) and 12% for ciprofoxacin (CIP). These high levels of quinolone-resistance in non-pathogenic strains isolated from children in this age group highlight the extensive use and the impact of the intake of this kind of antimicrobials in the community, showing the potential risk of the loss of their utility in the area. |
en_US |
dc.description.abstract |
El objetivo principal del estudio fue establecer el nivel de resistencia a antimicrobianos en un total de 222 cepas comensales de E. coli de origen fecal, en Perú. Las frecuencias de resistencia encontrados, frente los antimicrobianos evaluados, fueron: ampicilina (62,6%), cotrimoxazol (48,6%), tetraciclina (43,0%) y cloranfenicol (15,8%). Destacan los elevados niveles de resistencia a quinolonas: 32% al ácido nalidíxico (NAL) y 12% a ciprofloxacino (CIP). Estos elevados niveles hacia las quinolonas en cepas comensales aisladas en niños de esta franja de edad, realzan el uso extendido y el impacto de consumo de este tipo de antimicrobianos en la comunidad, mostrando el riesgo potencial de su pérdida de utilidad en el área. |
es_PE |
dc.language.iso |
spa |
|
dc.language.iso |
eng |
|
dc.publisher |
Instituto Nacional de Salud |
|
dc.relation.ispartofseries |
Revista Peruana de Medicina Experimental y Salud Pública |
|
dc.rights |
info:eu-repo/semantics/restrictedAccess |
|
dc.rights.uri |
https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es |
|
dc.subject |
Child |
en_US |
dc.subject |
Peru |
en_US |
dc.subject |
controlled study |
en_US |
dc.subject |
non age distribution |
en_US |
dc.subject |
ampicillin |
en_US |
dc.subject |
Escherichia coli |
en_US |
dc.subject |
feces analysis |
en_US |
dc.subject |
bacterium isolate |
en_US |
dc.subject |
ciprofloxacin |
en_US |
dc.subject |
quinoline derived antiinfective agent |
en_US |
dc.subject |
chloramphenicol |
en_US |
dc.subject |
cotrimoxazole |
en_US |
dc.subject |
nalidixic acid |
en_US |
dc.subject |
tetracycline |
en_US |
dc.subject |
Escherichia coli infection |
en_US |
dc.subject |
community assessment |
en_US |
dc.subject |
antibiotic resistance |
en_US |
dc.subject |
bacterial strain |
en_US |
dc.subject |
Quinolones |
en_US |
dc.subject |
child health |
en_US |
dc.subject |
drug use |
en_US |
dc.subject |
Fecal bacteria |
en_US |
dc.subject |
Microbial sensitivity tests |
en_US |
dc.title |
Niveles de resistencia a quinolonas y otros antimicrobianos en cepas de Escherichia coli comensales en niños de la zona periurbana de Lima, Perú |
es_PE |
dc.title.alternative |
Levels of quinolones resistance and other antimicrobial in non-pathogenic escherichia coli strains in children from the Periurban area of lima, Peru |
en_US |
dc.type |
info:eu-repo/semantics/article |
|
dc.identifier.doi |
https://doi.org/10.1590/s1726-46342012000100012 |
|
dc.subject.ocde |
https://purl.org/pe-repo/ocde/ford#3.03.05 |
|
dc.relation.issn |
1726-4642 |
|